Skip to main content

G 30mg 014 (Methylphenidate Hydrochloride Extended-Release (LA) 30 mg)

Pill with imprint G 30mg 014 is Yellow, Capsule-shape and has been identified as Methylphenidate Hydrochloride Extended-Release (LA) 30 mg. It is supplied by Granules Pharmaceuticals Inc.

Methylphenidate is used in the treatment of adhd; narcolepsy; depression and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Methylphenidate 30 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for G 30mg 014

Methylphenidate hydrochloride extended-release (LA) 30 mg G 30mg 014

Methylphenidate Hydrochloride Extended-Release (LA)

G 30mg 014
30 mg
Prescription only
Drug Class
CNS stimulants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
2 - High potential for abuse
Labeler / Supplier
Granules Pharmaceuticals Inc.
National Drug Code (NDC)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.